BiocOncoTK: a set of cancer-oriented software components for Bioconductor
August 13, 2021
Contents
1 Overview
This package provides a unified approach to programming with Bioconductor components to address problems in cancer genomics. Central concerns are:
- Ontology applications that systematize the conceptual structure of
cancer biology. There are particular concerns with structured vocabularies for
- general human anatomy
- experimental cell lines
- cancer therapeutics
- genome and epigenome elements and alterations related to cancer
- Communications infrastructure to support extraction and analysis of well-structured, self-describing
data from public archives and portals. Key resource centers of interest include
- TCGA, with curated representations through
- the ISB Cancer Genomics Cloud project
- Bioconductor’s curatedTCGAData interface
- The ISB pan-cancer atlas mirror
- TARGET through ISB-CGC
- cBioPortal; our main concern is to simplify usage of the RESTful API with R
- CLUE, “a cloud-based software platform for the analysis of perturbational datasets generated using gene expression (L1000) and proteomic (P100 and GCP) assays”
- Ivy Glioblastoma Atlas Project
- TCIA, with radiology and pathology components available through ISB/BigQuery
- TCRN: the TIES (Text Information Extraction System) Cancer Research Network – we’ll have to learn more about JWT with httr before progressing with this
- CONQUER, an archive of uniformly processed single-cell RNA-seq datasets, a number of which related to cancer. We have ‘curated’ CONQUER’s version of the GBM single cell study of Patel et al. 2014, with the large data component in an AWS S3 bucket. Below we indicate how to retrieve the Patel data for local computation. A larger, more recent single cell transcriptomics experiment in GBM is that of Darmanis et al. 2017. We curated the CONQUER representation of this experiment in a public HDF Object Store and describe how to use it below.
- TCGA, with curated representations through
- Remote analysis support to “move the computation to the data”. Bridging Google Cloud Datalab to the ISB TCGA and CCLE images is a first target.
- Social coding practice: at present, users and developers should use the issue tracker at the BiocOncoTK github repository to comment, critique, and propose new approaches.
2 Ontology
2.1 Oncotree
The NCI Thesaurus project distributes an OBO representation of oncotree. We can use this through the ontoProc (devel branch only) and ontologyPlot packages. Code for visualizing the location of ‘Glioblastoma’ in the context of its ‘siblings’ in the ontology follows.
3 Resource interfaces
3.1 PanCancer Atlas
In conjunction with restfulSE which handles aspects of the interface to BigQuery, this package provides tools for working with the PanCancer atlas project data.
3.1.1 Sample types
A key feature distinguishing the pancancer-atlas project from TCGA is the availability of data from normal tissue or metastatic or recurrent tumor samples. Codes are used to distinguish the different sources:
## SampleTypeLetterCode SampleType
## 1 TAM Additional Metastatic
## 2 TAP Additional - New Primary
## 3 TR Recurrent Solid Tumor
## 4 TB Primary Blood Derived Cancer - Peripheral Blood
## 5 TM Metastatic
## 6 NT Solid Tissue Normal
## 7 TP Primary solid Tumor3.1.2 SummarizedExperiments per assay per tumor or other sample type
The following code will run if you have a valid setting
for environment variable CGC_BILLING, to allow
BiocOncoTK::pancan_BQ() to generate a proper BigQueryConnection.
library(BiocOncoTK)
if (nchar(Sys.getenv("CGC_BILLING"))>0) {
pcbq = pancan_BQ() # basic connection
BRCA_mir = restfulSE::pancan_SE(pcbq)
}The result is
> BRCA_mir
class: SummarizedExperiment
dim: 743 1068
metadata(0):
assays(1): assay
rownames(743): hsa-miR-30d-3p hsa-miR-486-3p ... hsa-miR-525-3p
hsa-miR-892b
rowData names(0):
colnames(1068): TCGA-LD-A7W6 TCGA-BH-A18I ... TCGA-E9-A1N9 TCGA-B6-A0X0
colData names(746): bcr_patient_uuid bcr_patient_barcode ...
bilirubin_upper_limit days_to_last_known_alive3.1.3 Subsetting to normal
To shift attention to the normal tissue samples provided, use
to find
class: SummarizedExperiment
dim: 743 90
metadata(0):
assays(1): assay
rownames(743): hsa-miR-7641 hsa-miR-135a-5p ... hsa-miR-1323
hsa-miR-520d-5p
rowData names(0):
colnames(90): TCGA-BH-A18P TCGA-BH-A18S ... TCGA-E9-A1N6 TCGA-E9-A1N9
colData names(746): bcr_patient_uuid bcr_patient_barcode ...
bilirubin_upper_limit days_to_last_known_aliveThe intersection of the colnames from the two SummarizedExperiments thus formed (patients contributing both solid tumor and matched normal) has length 89.
3.1.4 Shifting focus to another tissue/assay
You need to know what type of sample has been assayed for the tumor type of interest.
Here is how you find the candidates.
bqcon %>% tbl(pancan_longname("rnaseq")) %>% filter(Study=="GBM") %>%
group_by(SampleTypeLetterCode) %>% summarise(n=n())To get RNA-seq on recurrent GBM samples:
3.1.5 Multiassay experiments per tumor
Suppose we want to work with the mRNA, RPPA, 27k/450k merged methylation and miRNA data together. We can invoke pancan_SE again, specifying the appropriate tables and fields.
BRCA_mrna = pancan_SE(pcbq,
assayDataTableName = pancan_longname("rnaseq"),
assayFeatureName = "Entrez",
assayValueFieldName = "normalized_count")
BRCA_rppa = pancan_SE(pcbq,
assayDataTableName = pancan_longname("RPPA"),
assayFeatureName = "Protein",
assayValueFieldName = "Value")
BRCA_meth = pancan_SE(pcbq,
assayDataTableName = pancan_longname("27k")[2],
assayFeatureName = "ID",
assayValueFieldName = "Beta")After obtaining the clinical data for BRCA with
library(dplyr)
library(magrittr)
clinBRCA = pcbq %>% tbl(pancan_longname("clinical")) %>%
filter(acronym=="BRCA") %>% as.data.frame()
rownames(clinBRCA) = clinBRCA[,2]
clinDF = DataFrame(clinBRCA)we use
library(MultiAssayExperiment)
brcaMAE = MultiAssayExperiment(
ExperimentList(rnaseq=BRCA_mrna, meth=BRCA_meth, rppa=BRCA_rppa,
mirna=BRCA_mir),colData=clinDF)to generate brcaMAE. No assay data are present in
this object, but data are retrieved on request.
> brcaMAE
A MultiAssayExperiment object of 4 listed
experiments with user-defined names and respective classes.
Containing an ExperimentList class object of length 4:
[1] rnaseq: SummarizedExperiment with 20531 rows and 1097 columns
[2] meth: SummarizedExperiment with 22601 rows and 1067 columns
[3] rppa: SummarizedExperiment with 259 rows and 873 columns
[4] mirna: SummarizedExperiment with 743 rows and 1068 columns
Features:
experiments() - obtain the ExperimentList instance
colData() - the primary/phenotype DataFrame
sampleMap() - the sample availability DataFrame
`$`, `[`, `[[` - extract colData columns, subset, or experiment
*Format() - convert into a long or wide DataFrame
assays() - convert ExperimentList to a SimpleList of matricesIt is convenient to check for sample availability for the
different assays using upsetSamples in MultiAssayExperiment.
The upset diagram for brcaMAE, showing sample availability per assay.
3.1.6 Reassessing immune infiltrate signatures in relation to microsatellite instability
The following code produces figure 1 of the restfulSE supplement.
library(BiocOncoTK)
infilGenes = c(`PD-L1`="CD274", `PD-L2`="PDCD1LG2", CD8A="CD8A")
tumcodes = c("COAD", "STAD", "UCEC")
combs = expand.grid(tumcode=tumcodes, ali=names(infilGenes),
stringsAsFactors=FALSE)
combs$sym = infilGenes[combs$ali]
bq = pancan_BQ()
exprByMSI = function(bq, tumcode, genesym, alias) {
print(tumcode)
if (missing(alias)) alias=genesym
ex = bindMSI(buildPancanSE(bq, tumcode, assay="RNASeqv2"))
ex = replaceRownames(ex)
data.frame(
patient_barcode=colnames(ex),
acronym=tumcode,
symbol = genesym,
alias = alias,
log2ex=log2(as.numeric(SummarizedExperiment::assay(ex[genesym,]))+1),
msicode = ifelse(ex$msiTest >= 4, ">=4", "<4"))
}
allshow = lapply(1:nrow(combs), function(x) exprByMSI(bq, combs$tumcode[x],
combs$sym[x], combs$ali[x]))
rr = do.call(rbind, allshow)
library(ggplot2)
png(file="microsatpan2.png")
ggplot(rr,
aes(msicode, log2ex)) + geom_boxplot() +
facet_grid(acronym~alias) +
ylab("log2(normalized expr. + 1)") +
xlab("microsatellite instability score")
dev.off()
3.2 Non-coding variants
The ggMutDens, ggFeatDens and ggFeatureSegs functions
were created to support the image given here. ggMutDens
in particular depends upon a working BigQuery connection to
the ISB-CGC PanCan-atlas project.
A view of non-coding mutation frequency in conjunction with TF binding site density and non-coding feature extents from Ensembl v75.
The detailed code for this display is:
library(BiocOncoTK)
library(AnnotationHub)
ah = AnnotationHub()
tc = ah[["AH5090"]]
tc$name = "TF"
tfplot = ggFeatDens(tc, mcolvbl="name")
library(EnsDb.Hsapiens.v75)
segplot=ggFeatureSegs()
bq = pancan_BQ() # requires that CGC_BILLING is set
mutplot = ggMutDens(bq)
library(cowplot)
plot_grid(mutplot, tfplot, segplot, align="v", nrow=3)3.3 Supporting infrastructure
The API for pancan_SE in restfulSE is complicated.
## function (bqcon, colDataTableName = "clinical_PANCAN_patient_with_followup",
## clinVars = basic_clinvars(), colDSubjectIdName = "bcr_patient_barcode",
## colDFilterField = "acronym", colDFilterValue = "BRCA", assayDataTableName = "pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16_annot",
## assayFeatureName = "ID", assaySampleTypeCode = "TP", subjectIDName = "ParticipantBarcode",
## tumorFieldName = "Study", tumorFieldValue = "BRCA", assayValueFieldName = "miRNAexpr")
## NULLLong, metadata-laden names are used for some tables, the clinical characteristics table has over 700 variables, and fields bearing information common to different tables may not have common names. Help is needed to permit programming for integrative analysis. BiocOncoTK provides the following assistance:
pancan_app: a shiny app that provides interactive table and data overviews
pancan_app
pancan_longname: a helper for generating the long table names using a hint that will be processed byagrep:
## RNASeqv2
## "EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp_annot"pancan_BQ: a function that will generate a BigQueryConnection instance provided billing code and Google authentication succeed.
3.4 TARGET
We assume that an ISB-CGC Google BigQuery billing number
is assigned to the environment variable CGC_BILLING.
First we list the tables available and have a look at the RNA-seq table.
billco = Sys.getenv("CGC_BILLING")
if (nchar(billco)>0) {
con = DBI::dbConnect(bigrquery::bigquery(), project="isb-cgc",
dataset="TARGET_hg38_data_v0", billing=billco)
DBI::dbListTables(con)
con %>% tbl("RNAseq_Gene_Expression") %>% glimpse()
}## Observations: NA
## Variables: 16
## $ project_short_name <chr> "TARGET-RT", "TARGET-RT", "TARGET-RT", "TARGE...
## $ case_barcode <chr> "TARGET-52-PARPFY", "TARGET-52-PARPFY", "TARG...
## $ sample_barcode <chr> "TARGET-52-PARPFY-11A", "TARGET-52-PARPFY-11A...
## $ aliquot_barcode <chr> "TARGET-52-PARPFY-11A-01R", "TARGET-52-PARPFY...
## $ gene_name <chr> "RIC8B", "ATOH7", "ZNF532", "XKR5", "RP11-33O...
## $ gene_type <chr> "protein_coding", "protein_coding", "protein_...
## $ Ensembl_gene_id <chr> "ENSG00000111785", "ENSG00000179774", "ENSG00...
## $ Ensembl_gene_id_v <chr> "ENSG00000111785.17", "ENSG00000179774.8", "E...
## $ HTSeq__Counts <int> 2396, 35, 5367, 17, 323, 1718, 1, 4, 3151, 25...
## $ HTSeq__FPKM <dbl> 3.212811104, 0.247184268, 4.693986615, 0.0353...
## $ HTSeq__FPKM_UQ <dbl> 7.790066e+04, 5.993448e+03, 1.138145e+05, 8.5...
## $ case_gdc_id <chr> "5cdd05ea-5285-50b7-971a-8bc005d01669", "5cdd...
## $ sample_gdc_id <chr> "7448bf2b-4ba0-5f98-ad0f-e87fa6619a43", "7448...
## $ aliquot_gdc_id <chr> "TARGET-52-PARPFY-11A-01R", "TARGET-52-PARPFY...
## $ file_gdc_id <chr> "f31fe296-402e-4e7d-b072-e4a6571a9c8a", "f31f...
## $ platform <chr> "Illumina", "Illumina", "Illumina", "Illumina...Now let’s see what tumor types are available.
if (nchar(billco)>0) {
con %>% tbl("RNAseq_Gene_Expression") %>%
select(project_short_name) %>%
group_by(project_short_name) %>%
summarise(n=n())
}## # Source: lazy query [?? x 2]
## # Database: BigQueryConnection
## project_short_name n
## <chr> <int>
## 1 TARGET-NBL 9495831
## 2 TARGET-AML 11310321
## 3 TARGET-RT 302415
## 4 TARGET-WT 7983756NBL is neuroblastoma, RT is rhabdoid tumor, WT is Wilms’ tumor.
3.5 CCLE
Figure 3a of Barretina et al 2012 shows that cell lines with NRAS mutations can be ordered according to a measure of PD-0325901 activity, and that this drug activity measure is correlated with expression of AHR. We will acquire the mutation and expression data using BigQuery as provided by ISB.
Here is a listing of all tables:
billco = Sys.getenv("CGC_BILLING")
if (nchar(billco)>0) {
con = DBI::dbConnect(bigrquery::bigquery(), project="isb-cgc",
dataset="ccle_201602_alpha", billing=billco)
DBI::dbListTables(con)
}## [1] "AffyU133_RMA_expression" "Copy_Number_segments"
## [3] "DataFile_info" "Mutation_calls"
## [5] "Sample_information" "fastqc_metrics"3.5.1 Mutation data
First we get an overview of the content:
muttab = con %>% tbl("Mutation_calls")
length(muttab %>% colnames())
muttab %>% select(Cell_line_primary_name, Hugo_Symbol,
Variant_Classification, cDNA_Change)%>% glimpse()## [1] 53Now let’s filter by NRAS and get a feel for how many observations are returned per cell line.
nrastab = muttab %>% select(Variant_Classification, Hugo_Symbol,
Cell_line_primary_name, CCLE_name) %>%
filter(Hugo_Symbol == "NRAS") %>% group_by(Hugo_Symbol)
nrastab %>% summarise(n=n())
nrasdf = nrastab %>% as.data.frame()We need to carve up the CCLE name to get the organ.
spl = function(x) {
z = strsplit(x, "_")
fir = vapply(z, function(x)x[1], character(1))
rest = vapply(z, function(x) paste(x[-1], collapse="_"), character(1))
list(fir, rest)
}
nrasdf$organ = spl(nrasdf$CCLE_name)[[2]]## Variant_Classification Hugo_Symbol Cell_line_primary_name
## 1 Missense_Mutation NRAS SNU-387
## 2 Missense_Mutation NRAS SNU-719
## 3 Missense_Mutation NRAS SNU-81
## 4 Missense_Mutation NRAS SW 1271
## 5 Missense_Mutation NRAS TF-1
## 6 Missense_Mutation NRAS THP-1
## CCLE_name organ
## 1 SNU387_LIVER LIVER
## 2 SNU719_STOMACH STOMACH
## 3 SNU81_LARGE_INTESTINE LARGE_INTESTINE
## 4 SW1271_LUNG LUNG
## 5 TF1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
## 6 THP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE HAEMATOPOIETIC_AND_LYMPHOID_TISSUE##
## AUTONOMIC_GANGLIA CENTRAL_NERVOUS_SYSTEM
## 2 1
## ENDOMETRIUM HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
## 3 25
## LARGE_INTESTINE LIVER
## 2 2
## LUNG OVARY
## 9 2
## SKIN SOFT_TISSUE
## 6 2
## STOMACH THYROID
## 1 1
## UPPER_AERODIGESTIVE_TRACT URINARY_TRACT
## 2 33.5.2 Expression data
Let’s obtain the expression of AHR for these NRAS-mutated cell lines.
ccexp = con %>% tbl("AffyU133_RMA_expression")
ccexp %>% glimpse()
ccexp %>% select(Cell_line_primary_name, RMA_normalized_expression,
HGNC_gene_symbol) %>% filter(HGNC_gene_symbol == "AHR") %>%
filter(Cell_line_primary_name %in% nrasdf$Cell_line_primary_name) %>%
as.data.frame() -> NRAS_AHR
head(NRAS_AHR)## Cell_line_primary_name RMA_normalized_expression HGNC_gene_symbol
## 1 SNU-719 11.859660 AHR
## 2 SNU-81 10.684210 AHR
## 3 SK-MEL-30 9.901173 AHR
## 4 KU-19-19 8.772602 AHR
## 5 L-363 3.704958 AHR
## 6 DND-41 4.110147 AHR3.5.3 Drug responsiveness data from CCLE, using pogos
The pogos package (submitted, see github.com/vjcitn/pogos) includes software to query pharmacodb.pmgenomics.ca. We will use this to develop drug-response profiles for PD-0325901.
We’ll define a responsiveness method, that takes a function f that is applied to the responses component of the dose-response profile.
responsiveness = function (x, f)
{
r = sapply(slot(x, "traces"), function(x) f(slot(slot(x,"DRProfiles")[[1]],"responses")))
data.frame(Cell_line_primary_name = slot(x,"cell_lines"), resp = r,
drug = slot(x,"drug"), dataset = x@dataset)
}The activity area for a compound in this design is defined as
## Cell_line_primary_name resp drug dataset
## 1 SK-MEL-30 2.8200 PD-0325901 CCLE
## 2 L-363 8.0061 PD-0325901 CCLE
## 3 SK-N-AS 4.0700 PD-0325901 CCLE
## 4 SNU-387 7.5157 PD-0325901 CCLE
## 5 Mino 6.8010 PD-0325901 CCLE
## 6 MOLP-8 5.4010 PD-0325901 CCLE## Min. 1st Qu. Median Mean 3rd Qu. Max.
## 1.920 3.730 5.178 4.958 5.927 8.006This is based on the supplement to Barretina et al. 2012. (There a slightly different formula in the addendum which uses notation that includes multiplying by a factor of i for dose index level i.)
Let’s merge the responsiveness data with the expression data for gene AHR.
## Cell_line_primary_name resp drug dataset RMA_normalized_expression
## 1 639-V 5.5290 PD-0325901 CCLE 4.711943
## 2 697 6.1672 PD-0325901 CCLE 4.803876
## HGNC_gene_symbol
## 1 AHR
## 2 AHR3.5.4 CLUE
The CLUE platform is an interface to results of work on the connectivity map at Broad
Institute. Usage of functions in this toolkit requires an API key, which can be
acquired through registration at clue.io. Set the environment variable
CLUE_KEY so that it can be found by Sys.getenv to use default key parameter
to functions described here.
A basic purpose of the interface to CLUE is to allow identification of gene signatures of perturbations in specific cellular contexts.
We have serialized data on cell lines and perturbagens available in the GSE70138 snapshot of LINCS.
## [1] "cell_id" "cell_type"
## [3] "base_cell_id" "precursor_cell_id"
## [5] "modification" "sample_type"
## [7] "primary_site" "subtype"
## [9] "original_growth_pattern" "provider_catalog_id"
## [11] "original_source_vendor" "donor_age"
## [13] "donor_sex" "donor_ethnicity"##
## -666 adipose
## 4 2
## autonomic ganglia blood
## 1 1
## bone breast
## 4 9
## central nervous system endometrium
## 3 3
## haematopoietic and lymphoid tissue kidney
## 8 6
## large intestine liver
## 17 3
## lung muscle
## 13 3
## ovary pancreas
## 6 2
## prostate skin
## 5 6
## stomach vascular system
## 1 1## [1] 2170 3## [1] "pert_id" "pert_iname" "pert_type"A number of API services have demonstration query expressions available in the package:
## [1] "cells" "genes" "profiles" "perts"
## [5] "sigs" "rep_drug_moas" "pcls"## $where
## $where$pert_desc
## [1] "imatinib"
##
## $where$cell_id
## [1] "MCF7"We use query_clue to query a service. Here we ask for
perturbagens that have EGFR among their targets. We’ll retrieve
a single ‘gold’ signature identifier.
if (nchar(Sys.getenv("CLUE_KEY"))>0) {
lkbytarg = query_clue(service="perts", filter=list(where=list(target="EGFR")))
print(names(lkbytarg[[1]]))
sig1 = lkbytarg[[1]]$sig_id_gold[1]
}Now we obtain the metadata about this signature.
if (nchar(Sys.getenv("CLUE_KEY"))>0) {
sig1d = query_clue(service="sigs", filter=list(where=list(sig_id=sig1)))
print(names(sig1d[[1]]))
print(head(sig1d[[1]]$pert_iname)) # perturbagen
print(head(sig1d[[1]]$cell_id)) # cell type
print(head(sig1d[[1]]$dn50_lm)) # some downregulated genes among the landmark
print(head(sig1d[[1]]$up50_lm)) # some upregulated genes among the landmark
}3.5.4.1 Example
Task: Assess the effects of perturbagens on transcription in the NPC cell line. We’ll check for recurrence of landmark genes among the top 50 upregulated for perturbagens that are identified as HDAC inhibitors.
# use pertClasses() to get names of perturbagen classes in Clue
if (nchar(Sys.getenv("CLUE_KEY"))>0) {
tuinh = query_clue("perts",
filter=list(where=list(pcl_membership=list(inq=list("CP_HDAC_INHIBITOR")))))
inames_tu = sapply(tuinh, function(x)x$pert_iname)
npcSigs = query_clue(service="sigs", filter=list(where=list(cell_id="NPC")))
length(npcSigs)
gns = lapply(npcSigs, function(x) x$up50_lm)
perts = lapply(npcSigs, function(x) x$pert_iname)
touse = which(perts %in% inames_tu)
rec = names(tab <- sort(table(unlist(gns[touse])),decreasing=TRUE)[1:5])
cbind(select(org.Hs.eg.db, keys=rec, columns="SYMBOL"), n=as.numeric(tab))
}We can abstract from this process a function that takes perturbagen classes and cell lines to deliver collections of LINCS signatures of genes considered to produce transcriptional activities of certain kinds.
4 Curated single cell expression data from cancer studies
In this section we illustrate different modalities for acquiring and working with single cell transcriptomics data, after processing by the CONQUER workflow.
4.1 Patel 2014
The Patel et al. experiment assayed 864 cells.
A standard in-memory representation is straightforward.
The curated SummarizedExperiment is distributed in an AWS S3
bucket sponsored by the Bioconductor Foundation. The loadPatel
function retrieves this and places it in a `r Biocpkg(“BiocFileCache”)
instance.
if (interactive()) {
patelSE = loadPatel() # uses BiocFileCache
patelSE
assay(patelSE[1:4,1:3]) # in memory
}Exploratory analysis of this dataset is described in the companion vignette on single cell transcriptomics for GBM.
4.2 Darmanis 2017
The Darmanis et al. experiment assayed over 3500 cells. The
CONQUER compressed RDS representation of all the data is about
4 GB on disk. The gene level quantifications and sample-level data
were manually extracted from this archive. The gene level quantifications
in the count_lstpm form were then loaded into a public HDF object store
sponsored by John Readey. These data will persist in this format for some time; a
Bioconductor-sponsored representation will be introduced as soon as possible.
if (rhdf5client::check_hsds()) {
darmSE = BiocOncoTK::darmGBMcls # count_lstpm from CONQUER
darmSE
assay(darmSE) # out of memory
}## <65218 x 3584> matrix of class DelayedMatrix and type "double":
## GSM2243439 GSM2243440 ... GSM2247076 GSM2247077
## ENSG00000000003.14 0.000000 0.000000 . 0.00000 0.00000
## ENSG00000000005.5 0.000000 0.000000 . 0.00000 0.00000
## ENSG00000000419.12 0.000000 0.000000 . 0.00000 0.00000
## ENSG00000000457.13 5.335452 11.685833 . 0.00000 14.01612
## ENSG00000000460.16 0.000000 0.000000 . 0.00000 0.00000
## ... . . . . .
## ERCC-00164 0.0000 0.0000 . 0.00000 0.00000
## ERCC-00165 480.6895 1228.1385 . 0.00000 0.00000
## ERCC-00168 0.0000 0.0000 . 0.00000 0.00000
## ERCC-00170 0.0000 610.8300 . 0.00000 0.00000
## ERCC-00171 10155.8034 25366.3010 . 4.01555 2531.888625 Summary
BiocOncoTK is a result of work carried out under NCI ITCR U01 “Accelerating
cancer genomics with cloud-scale Bioconductor”. This package illustrates
several Bioconductor-based representations of cancer data and metadata.
Some of the resources, such as the PanCancer atlas, CCLE, and high-resolution
single-cell transcriptomics studies are sufficiently large that cloud-oriented
representation and analysis may be cost-effective. As this package matures,
additional resources will be highlighted, with particular attention to
integration processes.